Radifocus (Terumo) Versus Silverway (Asahi) to Deliver Catheters During Cardiac Catheterization (RADVES)

July 12, 2022 updated by: Koen Ameloot, Ziekenhuis Oost-Limburg
In some cases the standard J-tip guidewire cannot deliver the catheter into the aortic root, because of arterial loops or spasm. In these cases a hydrophilic guidewire (Terumo) gives the right lubricity and good shape retention to guide the catheter through the artery. However, the Terumo wire does not give much torque and could therefore easily penetrate side branches and cause dissection or perforation. The latest Silverway guidewire has some new advantages which is easier to guide and could cause less complications while faster delivery of catheters to the aortic valve. The investigators aim to compare both guide wires.

Study Overview

Status

Completed

Conditions

Detailed Description

During cardiac catheterization a catheter is threaded through the radial arteries to the aortic root with the support of a guide wire. The standard workhorse to deliver the catheter is a J-tip guidewire (spring coil wire). However, in patients with arterial tortuosity or spasm, this guidewire has low lubricity and no torque to direct the catheter because the outer coil and core are not connected together.

If this problem is encountered, interventional cardiologists will use a hydrophilic polymer-coated guide wire. Up to date there are several hydrophilic coated guide wires available. One of these is the Radifocus Guide Wire M (Terumo, Japan). Although it has better torque transmission than the spring wire, it still has low torque transmission due to a Nitinol core structure, is less supportive and can easily enter side branches because of the high lubricity and therefore might cause dissections or perforations.

In some cases, coronary angioplasty guide wires are needed to negotiate a highly tortuous artery, but they lack the support to advance the catheter.

Recently, the Silverway Guide Wire has been created (Asahi Intecc Co, LTD., Japan) to overcome the problems that a spring- and polymer wire have. Features that this new guide wire provide is hybrid coating and ACT ONE technology that connects the wire core and coil to ensure one to one torque transmission The investigators aim to compare both guide wires in deliverability, workability and complication rate.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Genk, Limburg, Belgium, 3600
        • Ziekenhuis Oost-Limburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Indication for radial artery access for diagnostic cardiac catheterization
  • Being able to receive the per standard protocol Verapamil and Nitroglycerin administration via radial artery
  • Not able to deliver a diagnostic or guiding catheter to the aortic root by means of the standard J tip wire
  • No signs of early complication after initial attempt with the J tip wire such as dissection, perforation or hematoma
  • Age ≥ 18 years

Exclusion Criteria:

  • Femoral or brachial artery access
  • Patients with known CREST syndrome or other forms of scleroderma
  • Emergent indication for cardiac catheterization such as an acute coronary syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Below the shoulder vascular anomaly
If the standard J-tip guidewire does not cross a vascular anomaly located below the shoulder
The Radifocus guidewire is a hydrophilic coated guidewire that is used when a standard J-tip guidewire does not cross a vascular anomaly
Active Comparator: Above the shoulder vascular anomaly
If the standard J-tip guidewire does not cross a vascular anomaly located above the shoulder
The Silverway guidewire is a newly developed guidewire to overcome the problems the Radifocus guidewire has

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time in seconds from introduction to aortic root
Time Frame: During procedure
Measuring time from entering the guidewire in the catheter to delivery of the catheter to the aortic root (in seconds)
During procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The ability of the study wire to deliver the catheter to the aortic root
Time Frame: During procedure
If the study wire is able to deliver the catheter to the aortic root
During procedure
Change of access site
Time Frame: During procedure
Is change of access site necessary?
During procedure
Interventional cardiologists' survey of grading parameters working with the guide wire
Time Frame: Directly after procedure. Scale: not satisfactory (1) - somewhat satisfactory (2) - satisfactory (3)
The interventional cardiologist who used the study wire must fill up a survey after procedure to grade the workability and deliverability of the study wire
Directly after procedure. Scale: not satisfactory (1) - somewhat satisfactory (2) - satisfactory (3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Koen Ameloot, Dr., Ziekenhuis Oost-Limburg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2022

Primary Completion (Actual)

July 12, 2022

Study Completion (Actual)

July 12, 2022

Study Registration Dates

First Submitted

January 29, 2022

First Submitted That Met QC Criteria

January 29, 2022

First Posted (Actual)

February 9, 2022

Study Record Updates

Last Update Posted (Actual)

July 14, 2022

Last Update Submitted That Met QC Criteria

July 12, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anomalies Vascular

Clinical Trials on Radifocus guidewire

3
Subscribe